Another report of 51 RA patients evidenced that upregulation of three IFN response genes negatively predicted response to RTX at week 12 (9/24 versus 20/27 [R2 = 0.17; p = 0.01]) [68]. The gene discussed is IFNA1; the disease is rheumatoid arthritis.